MONTRÉAL, Jan. 11, 2019 /CNW/ – Cannara Biotech Inc. (“Cannara” or the “Company”), a vertically integrated Cannabis company focused on cannabis derivative products, is pleased to announce that its common shares will begin trading on Monday, January 14, 2019 on the Canadian Securities Exchange (“CSE”) under the symbol “LOVE”.
“Since early 2017, we have been quietly assembling and advancing the necessary infrastructure to build Canada’s premier cannabis company,” said Zohar Krivorot, President and CEO of Cannara. “Today, with one of the largest indoor facilities in Canada and the largest in Quebec, we are well positioned to execute on a strategic plan including cultivation, product branding, derivative products and development of intellectual property. We are excited to begin our next phase as a public company and to continue our growth trajectory.”